Error: Could not add to watchlist. X

Cellceutix Corp

+ Watchlist
C0C:GR
Berlin
Price not available for C0C:GR
EUR
Volume
0
Previous Close
2.50
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (EUR)
-
Shares Outstanding (m)
117.719
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Cellceutix Corporation is a development-stage biopharmaceutical company. The Company's current portfolio of product candidates in pre-clinical development includes anti-cancer agents targeting multiple tumors, candidate targeting rheumatoid arthritis, candidate with potential for indications of osteo-arthritis/asthma, candidate being developed for autism.
ADDRESS
100 Cumming Center
Suite 151-B
Beverly, MA 01915
United States
PHONE
1-978-236-8717
  • Leo Ehrlich
    Chairman/CEO/CFO
  • Krishna Menon
    Pres/Chief Scientific Ofcr/Founder
  • William James Alexander
    Chief Operations Officer
  • Daniel M Jorgensen
    Chief Medical Officer
Show More